Discussion on critical points for a tailored therapy to cure hepatitis C virus infection

Hepatitis C virus (HCV) infects around 71 million people worldwide and in 2018 it is still a major health problem. Since 2011, anti-HCV therapy with availability of direct-acting antiviral drugs has revolutionized the clinical response and paved the way to eradication strategies. However, despite th...

Descripción completa

Detalles Bibliográficos
Autores principales: Marascio, Nadia, Quirino, Angela, Barreca, Giorgio Settimo, Galati, Luisa, Costa, Chiara, Pisani, Vincenzo, Mazzitelli, Maria, Matera, Giovanni, Liberto, Maria Carla, Focà, Alfredo, Torti, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435970/
https://www.ncbi.nlm.nih.gov/pubmed/30669818
http://dx.doi.org/10.3350/cmh.2018.0061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435970/
https://www.ncbi.nlm.nih.gov/pubmed/30669818
http://dx.doi.org/10.3350/cmh.2018.0061

Ejemplares similares